Health

The Union Cabinet chaired by the Prime Minister, Shri Narendra Modi has approved establishment of a new All India Institute of Medical Sciences (AIIMS) at Darbhanga, Bihar. This will be established under the Pradhan Mantri Swasthya Suraksha Yojana (PMSSY). The Cabinet also approved creation of one post of Director in the basic pay of Rs 2,25,000/- (fixed) plus NPA (however pay + NPA would not exceed Rs 2,37,500/-) for the above AIIMS.

India’s journey of a fast growing Recovery Rate has crossed a milestone on Monday. On a continuous upward trajectory, the Recovery Rate has touched 78.00% reflecting the increasing number of high recoveries per day.

Using nudge theory that involves subtly leading people to desired directions, a study of India’s public policy response to Covid-19 has concluded that nudges from Prime Minister Narendra Modi were critical in creating herd effect on lockdown and social distancing norms across the country.

A team of doctors in Hyderabad have performed the country’s first double lung transplant on a COVID-19 patient. The patient, Rizwan from Chandigarh in Punjab, was suffering from a severe lung problem called ‘sarcoidosis’ that affected the lungs significantly which led to ‘fibrosis’ of the lungs.

In reply to a query on sero-survey, DG, ICMR stated, 50 out of 70 districts have completed the second round of sero-survey. The results of the entire country’s sero-survey should be available within two weeks.

Shri Hardeep S Puri, MoS, (I/C), Ministry of Housing and Urban Affairs has announced the SOP guidelines for metro operations in a media interaction today. As per MHA order No 40-3/2020-DM-I(A) dated 29.8.2020, metro services will resume from 7th September, 2020 in a graded manner. For this purpose, SOP guidelines have been prepared by Ministry of Housing and Urban Affairs, which have been concurred by the Ministry of Home Affairs.

India continues to report one of the lowest COVID Case Fatality Rates (CFR) when compared to several other countries. While the global CFR stands at 3.3% as on date, the comparative figure for India is 1.76%

The blood samples collected from the volunteers who received the vaccine were to ascertain how effective the vaccine was in terms of the level of antibodies developed, Dr Rao said, adding that there had been ‘no side effects’ in the first phase trial of the vaccine. The IMS and SUM Hospital is one of the 12 medical centres in the country chosen by the Indian Council for Medical Research (ICMR) for conducting the human trial of the vaccine developed by Hyderabad-based Bharat Biotech.